Anti-CD3/28 mediated expansion of macaque CD4+ T cells is polyclonal and provides extended survival after adoptive transfer

Journal of Medical Primatology

Volumn 36, Issue 4-5, 2007, Pages 206-218

  Onlamoon, Nattawat ^a,b   Plagman, Nicholas ^a   Rogers, Kenneth A ^a   Mayne, Ann E ^a   Bostik, Pavel ^a   Pattanapanyasat, Kovit ^b   Ansari, Aftab A ^a   Villinger, François ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adoptive transfer; CD4 T cell; Expansion

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; POLYCLONAL ANTIBODY; TELOMERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOPTIVE TRANSFER; ANIMAL CELL; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; EX VIVO STUDY; IMMUNOTHERAPY; LENTIVIRINAE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACACA; MONKEY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL RATE; TIME;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOTHERAPY, ADOPTIVE; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TELOMERASE;

SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 34547104026     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2007.00238.x     Document Type: Conference Paper

References (62)

1. Allen TM, Telleher AD, Zaunders J, Walker BD: STI and beyond: the prospects of boosting anti-HIV immune responses. Trends Immunol 2002; 23: 456-60.
2. Ansari AA, Mayne AE, Onlamoon N, Pattanapanyasat K, Mori K, Villinger F: Use of recombinant cytokines for optimized induction of antiviral immunity against SIV in the nonhuman primate model of human AIDS. Immunol Res 2004; 29: 1-18.
3. Ansari AA, Mayne AE, Sundstrom JB, Bostik P, Grimm B, Altman JD, Villinger F: Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques. J Virol 2002; 76: 1731-43.
4. Autran B, Carcelaint G, Li TS, Gorochov G, Blanc C, Renaud M, Durali M, Mathez D, Calvez V, Leibowitch J, Katlama C, Debre P: Restoration of the immune system with anti-retroviral therapy. Immunol Lett 1999; 66: 207-11.
5. Ballon G, Ometto L, Righetti E, Cattelan AM, Masiero S, Zanchetta M, Chieco-Bianchi L, De Rossi A: Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis 2001; 183: 417-24.
6. Blais ME, LouiA I, Perreault C: T-cell development: an extrathymic perspective. Immunol Rev 2006; 209: 103-14.
7. Bostik P, Brice GT, Greenberg KP, Mayne AE, Villinger F, Lewis MG, Ansari AA: Inverse correlation of telomerase activity/proliferation of CD4+ T lymphocytes and disease progression in simian immunodeficiency virus-infected nonhuman primates. J Acquir Immune Defic Syndr 2000; 24: 89-99.
8. Brenchley JM, Ruff LE, Casazza JP, Koup RA, Price DA, Douek DC: Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo. J Virol 2006; 80: 6801-9.
9. Brice GT, Mayne AE, Villinger F, Ansari AA: A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses. J Acquir Immune Defic Syndr 2000; 24: 10-22.
10. Brice GT, Riley JL, Villinger F, Mayne A, Hillyer CD, June CH, Ansari AA: Development of an animal model for autotransfusionItherapy: in vitro characterization and analysis of anti-CD3/CD28 expanded cells. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 210-20.
11. Brooks DG, McGavern DB, Oldstone MB: Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest 2006; 116: 1675-85.
12. Carroll RG, Riley JL, Levine BL, Feng Y, Kaushal S, Ritchey DW, Bernstein W, Weislow OS, Brown CR, Berger EA, June CH, St Louis DC: Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science 1997; 276: 273-6.
13. Chen LF, Hoy J, Lewin SR: Ten years of highly active antiretroviral therapy for HIV infection. Med J Aust 2007; 186: 146-51.
14. Dagarag M, Evazyan T, Rao N, Effros RB: Genetic manipulation of telomerase in HIV-specific CD8+ T cells: Enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol 2004; 173: 6303-11.
15. de Alboran IM, Robles MS, Bras A, Baena E, Martinez AC: Cell death during lymphocyte development and activation. Semin Immunol 2003; 15: 125-33.
16. de Bethune MP, Hertogs K: Screening and selecting for optimized antiretroviral drugs: Rising to the challenge of drug resistance. Curr Med Res Opin 2006; 22: 2603-12.
17. Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM: A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther 2002; 5: 788-97.
18. Deshpande A, Jauvin V, Magnin N, Pinson P, Faure M, Masquelier B, Aurillac-Lavignolle V, Fleury HJ: Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: Resistance to AR. AIDS Res Hum Retroviruses 2007; 23: 335-40.
19. Dhillon NK, Sui Y, Potula R, Dhillon S, Adany I, Li Z, Villinger F, Pinson D, Narayan O, Buch S: Inhibition of pathogenic SHIV replication in macaques treated with antisense DNA of interleukin-4. Blood 2005; 105: 3094-9.
20. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, Okamoto Y, Casazza JP, Kuruppu J, Kunstman K, Wolinsky S, Grossman Z, Dybul M, Oxenius A, Price DA, Connors M, Koup RA: HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417: 95-8.
21. Folks T, Rowe T, Villinger F, Parekh B, Mayne A, Anderson D, McClure H, Ansari AA: Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques. J Med Primatol 1997; 26: 181-9.
22. Franzese O, Adamo R, Pollicita M, Comandini A, Laudisi A, Perno CF, Aquaro S, Bonmassar E: Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1). J Med Virol 2007; 79: 639-46.
23. Goetz MB, Ferguson MR, Han X, McMillan G, St Clair M, Pappa KA, McClernon DR, O'Brien WA: Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure. J Acquir Immune Defic Syndr 2006; 43: 541-9.
24. Ho DD: HIV-1 viraemia and influenza. Lancet 1992; 339: 1549.
25. Holte SE, Melvin AJ, Mullins JI, Tobin NH, Frenkel LM: Density-dependent decay in HIV-1 dynamics. J Acquir Immune Defic Syndr 2006; 41: 266-76.
26. Hryniewicz A, Price DA, Moniuszko M, Boasso A, Edghill-Spano Y, West SM, Venzon D, Vaccari M, Tsai WP, Tryniszewska E, Nacsa J, Villinger F, Ansari AA, Trindade CJ, Morre M, Brooks D, Arlen P, Brown HJ, Kitchen CM, Zack JA, Douek DC, Shearer GM, Lewis MG, Koup RA, Franchini G: Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol 2007; 178: 3492-504.
27. Kalams SA, Walker BD: The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp.Med. 1998; 188: 2199-204.
28. Kaufmann DE, Lichterfeld M, Altfeld M, Addo MM, Johnston MN, Lee PK, Wagner BS, Kalife ET, Strick D, Rosenberg ES, Walker BD: Limited durability of viral control following treated acute HIV infection. PLoS Med 2004; 1: E36.
29. King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB: Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis 2000; 181: 725-8.
30. Lange CG, Lederman MM: Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother 2003; 51: 1-4.
31. Levine BL, Cotte J, Small CC, Carroll RG, Riley JL, Bernstein WB, Van Epps DE, Hardwick RA, June CH: Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation. J Hematother 1998; 7: 437-48.
32. Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X, Binder GK, Slepushkin V, Lemiale F, Mascola JR, Bushman FD, Dropulic B, June CH: Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006; 103: 17372-7.
33. Lisziewicz J, Lori F: Structured treatment interruptions in HIV/AIDS therapy. Microbes Infect 2002; 4: 207-14.
34. Lori F, Foli A, Lisziewicz J: Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: A review of recent clinical data and future prospects. J Antimicrob Chemother 2002; 50: 155-60.
35. Maggiolo F, Ripamonti D, Torti C, Arici C, Antinori A, Quiros-Roldan E, Minoli L, Sighinolfi L, Nasta P, Suter F: The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens. Antivir Ther 2006; 11: 923-9.
36. Margolis DM, ArchiT NM: Attacking HIV provirus: therapeutic strategies to disrupt persistent infection. Infect Disord Drug Targets 2006; 6: 369-76.
37. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M: Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434: 1093-7.
38. Mitsuyasu RT, Anton PA, Deeks SG, Scadden DT, Connick E, Downs MT, Bakker A, Roberts MR, June CH, Jalali S, Lin AA, Pennathur-Das R, Hege KM: Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects. Blood 2000; 96: 785-93.
39. Moniuszko M, Fry T, Tsai WP, Morre M, Assouline B, Cortez P, Lewis MG, Cairns S, Mackall C, Franchini G: Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol 2004; 78: 9740-9.
40. Moss RB, Jensen FC, Carlo DJ, Wallace MR: The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs). Curr Drug Targets Infect Disord 2001; 1: 11-7.
41. Mueller YM, Petrovas C, Bojczuk PM, Dimitriou ID, Beer B, Silvera P, Villinger F, Cairns JS, Gracely EJ, Lewis MG, Katsikis PD: Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. J Virol 2005; 79: 4877-85.
42. Napravnik S, Keys JR, Quinlivan EB, Wohl DA, Mikeal OV, Eron JJ Jr: Triple-class antiretroviral drug resistance: Risk and predictors among HIV-1-infected patients. Aids 2007; 21: 825-34.
43. Nichols WS, Schneider S, Chan RC, Farthing CF, Daar ES: Increased CD4+ T-lymphocyte senescence fraction in advanced human immunodeficiency virus type 1 infection. Scand J Immunol 1999; 49: 302-6.
44. Nugeyre MT, Monceaux V, Beq S, Cumont MC, Ho Tsong Fang R, Chene L, Morre M, Barre-Sinoussi F, Hurtrel B, Israel N: IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J Immunol 2003; 171: 4447-53.
45. Oelke M, Krueger C, Schneck JP: Technological advances in adoptive immunotherapy. Drugs Today (Barc) 2005; 41: 13-21.
46. Onlamoon N, Hudson K, Bryan P, Mayne AE, Bonyhadi M, Berenson R, Sundstrom BJ, Bostik P, Ansari AA, Villinger F: Optimization of in vitro expansion of macaque CD4 T cells using anti-CD3 and co-stimulation for autotransfusion therapy. J Med Primatol 2006; 35: 178-93.
47. Ostrowski MA, Krakauer DC, Li Y, Justement SJ, Learn G, Ehler LA, Stanley SK, Nowak M, Fauci AS: Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies. J Virol 1998; 72: 7772-84.
48. Paiardini M, Cervasi B, Dunham R, Sumpter B, Radziewicz H, Silvestri G: Cell-cycle dysregulation in the immunopathogenesis of AIDS. Immunol Res 2004; 29: 253-68.
49. Paiardini M, Cervasi B, Sumpter B, McClure HM, Sodora DL, Magnani M, Staprans SI, Piedimonte G, Silvestri G: Perturbations of cell cycle control in T cells contribute to the different outcomes of simian immunodeficiency virus infection in rhesus macaques and sooty mangabeys. J Virol 2006; 80: 634-42.
50. Picker LJ, Reed-Inderbitzin R-IE, Hagen SI, Edgar JB, Legasse A, Planer S, Piatak M, Lifson JD, Maino VC, Axthelm MK, Villinger F: IL-15 induces CD4+ effector memory T cell production and tissue emigration in non-human primates. J Clin Invest 2006; 116: 1514-24.
51. Reynoso R, Minces L, Salomon H, Quarleri J: HIV-1 infection downregulates nuclear telomerase activity on lymphoblastoic cells without affecting the enzymatic components at the transcriptional level. AIDS Res Hum Retroviruses 2006; 22: 425-9.
52. Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, Roche K, Schwartzentruber DJ, Fox CH, Fauci AS: Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996; 334: 1222-30.
53. Valdez H, Connick E, Smith KY, Lederman MM, Bosch RJ, Kim RS, St Clair M, Kuritzkes DR, Kessler H, Fox L, Blanchard-Vargas M, Landay A: Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. Aids 2002; 16: 1859-66.
54. Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey J, Fox L, Namkung A, Estep S, Moss R, Sahner D, Lederman MM: Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: Results of A5046s. J Infect Dis 2003; 187: 320-5.
55. Villinger F, Brice GT, Mayne AE, Bostik P, Mori K, June CH, Ansari AA: Adoptive transfer of simian immunodeficiency virus (SIV) naive autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status. Blood 2002; 99: 590-9.
56. Villinger F, Bucur S, Chikkala NF, Brar SS, Bostik P, Mayne AE, Adams J, Lee ME, Novembre FJ, Gately MK, Ansari AA, Hillyer CD: In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS. AIDS Res Hum Retroviruses 2000; 16: 751-63.
57. Villinger F, Miller R, Mori K, Mayne AE, Bostik P, Sundstrom JB, Sugimoto C, Ansari AA: IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 2004; 22: 3510-21.
58. Villinger F, Rowe T, Parekh BS, Green TA, Mayne AE, Grimm B, McClure HM, Lackner AA, Dailey PJ, Ansari AA, Folks TM: Chronic immune stimulation accelerates SIV-induced disease progression. J Med Primatol 2001; 30: 254-9.
59. Watanabe N, Sypek JP, Mittler S, Reimann KA, Flores-Villanueva P, Voss G, Lord CI, Letvin NL: Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys. AIDS Res Hum Retroviruses 1998; 14: 393-9.
60. Weissman D, Montaner LJ: Immune reconstitution. Clin Lab Med 2002; 22: 719-40.
61. Yue FY, Kovacs CM, Dimayuga RC, Gu XX, Parks P, Kaul R, Ostrowski MA: Preferential apoptosis of HIV-1-specific CD4+ T cells. J Immunol 2005; 174: 2196-204.
62. Zou W, Coulomb A, Venet A, Foussat A, Berrebi D, Beyer C, Crevon MC, Minty A, Couedel-Courteille A, Vivier E, Capron F, Galanaud P, Emilie D: Administration of interleukin 13 to simian immunodeficiency virus-infected macaques: Induction of intestinal epithelial atrophy. AIDS Res Hum Retroviruses 1998; 14: 775-83.